Literature DB >> 26942744

MALDI-TOF MS performance compared to direct examination, culture, and 16S rDNA PCR for the rapid diagnosis of bone and joint infections.

E Lallemand1, G Coiffier2,3,4, C Arvieux3,5, E Brillet3,6, P Guggenbuhl2,3,4,7, A Jolivet-Gougeon8,9,10,11.   

Abstract

The rapid identification of bacterial species involved in bone and joint infections (BJI) is an important element to optimize the diagnosis and care of patients. The aim of this study was to evaluate the usefulness of matrix-assisted laser desorption ionization mass spectrometry (MALDI-TOF MS) for the rapid diagnosis of bone infections, directly on synovial fluid (SF) or on crushed osteoarticular samples (CS). From January to October 2013, we prospectively analyzed 111 osteoarticular samples (bone and joint samples, BJS) from 78 patients in care at the University Hospital of Rennes, France. The diagnosis procedure leading to the sample collection was linked to a suspicion of infection, inflammatory disease, arthritis, or for any bone or joint abnormalities. Standard bacteriological diagnosis and molecular biology analysis [16S rRNA polymerase chain reaction (PCR) and sequencing] were conducted. In addition, analysis by MALDI-TOF MS was performed directly on the osteoarticular samples, as soon as the amount allowed. Culture, which remains the gold standard for the diagnosis of BJI, has the highest sensitivity (85.9 %) and remains necessary to test antimicrobial susceptibility. The 16S rDNA PCR results were positive in the group with positive BJI (28.6 %) and negative in the group without infection. Direct examination remains insensitive (31.7 %) but more effective than MALDI-TOF MS directly on the sample (6.3 %). The specificity was 100 % in all cases, except for culture (74.5 %). Bacterial culture remains the gold standard, especially enrichment in blood bottles. Direct analysis of bone samples with MALDI-TOF MS is not useful, possibly due to the low inoculum of BJS.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26942744     DOI: 10.1007/s10096-016-2608-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  37 in total

1.  Robustness of two MALDI-TOF mass spectrometry systems for bacterial identification.

Authors:  Etienne Carbonnelle; Patrick Grohs; Hervé Jacquier; Nesrine Day; Sylvie Tenza; Alexandra Dewailly; Odile Vissouarn; Martin Rottman; Jean-Louis Herrmann; Isabelle Podglajen; Laurent Raskine
Journal:  J Microbiol Methods       Date:  2012-03-08       Impact factor: 2.363

2.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry as an alternative to 16S rRNA gene sequencing for identification of difficult-to-identify bacterial strains.

Authors:  A Bizzini; K Jaton; D Romo; J Bille; G Prod'hom; G Greub
Journal:  J Clin Microbiol       Date:  2010-11-24       Impact factor: 5.948

3.  Direct identification of bacteria in urine samples by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and relevance of defensins as interfering factors.

Authors:  Hedda Luise Köhling; Anna Bittner; Karl-Dieter Müller; Jan Buer; Markus Becker; Herbert Rübben; Albert Wolfgang Rettenmeier; Frank Mosel
Journal:  J Med Microbiol       Date:  2012-01-23       Impact factor: 2.472

4.  Prosthetic joint infection diagnosis using broad-range PCR of biofilms dislodged from knee and hip arthroplasty surfaces using sonication.

Authors:  Eric Gomez; Charles Cazanave; Scott A Cunningham; Kerryl E Greenwood-Quaintance; James M Steckelberg; James R Uhl; Arlen D Hanssen; Melissa J Karau; Suzannah M Schmidt; Douglas R Osmon; Elie F Berbari; Jayawant Mandrekar; Robin Patel
Journal:  J Clin Microbiol       Date:  2012-08-15       Impact factor: 5.948

5.  Performance of a matrix-assisted laser desorption ionization-time-of-flight mass spectrometry system for the identification of bacterial isolates in the clinical routine laboratory.

Authors:  Ulrich Eigner; Martin Holfelder; Klaus Oberdorfer; Ulrike Betz-Wild; Daniela Bertsch; Anne-Marie Fahr
Journal:  Clin Lab       Date:  2009       Impact factor: 1.138

6.  [Recommendations for clinical practice. Osteo-articular infection therapy according to materials used (prosthesis, implants, osteosynthesis)].

Authors: 
Journal:  Med Mal Infect       Date:  2009-10       Impact factor: 2.152

7.  Multicenter comparison of BACTEC 9050 and BACTEC 9240 blood culture systems.

Authors:  P R Murray; G E Hollick; R C Jerris; M L Wilson
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

8.  High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories.

Authors:  S Q van Veen; E C J Claas; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2010-01-06       Impact factor: 5.948

9.  Analysis of 525 samples to determine the usefulness of PCR amplification and sequencing of the 16S rRNA gene for diagnosis of bone and joint infections.

Authors:  Florence Fenollar; Véronique Roux; Andréas Stein; Michel Drancourt; Didier Raoult
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

10.  Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy.

Authors:  Peter Schäfer; Bernd Fink; Dieter Sandow; Andreas Margull; Irina Berger; Lars Frommelt
Journal:  Clin Infect Dis       Date:  2008-12-01       Impact factor: 9.079

View more
  3 in total

Review 1.  A Real Pain: Diagnostic Quandaries and Septic Arthritis.

Authors:  Cristina Costales; Susan M Butler-Wu
Journal:  J Clin Microbiol       Date:  2018-01-24       Impact factor: 5.948

2.  Emerging Diabetic Foot Ulcer Microbiome Analysis Using Cutting Edge Technologies.

Authors:  Brian M Schmidt
Journal:  J Diabetes Sci Technol       Date:  2021-02-12

3.  Direct identification of microorganisms from thioglycolate broth by MALDI-TOF MS.

Authors:  Jorge Arca-Suárez; Fátima Galán-Sánchez; Pilar Marin-Casanova; Manuel A Rodríguez-Iglesias
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.